TRYPF   $0.055  1.85% Market Closed

Tryp Therapeutics Inc
Total Cash 2.06M
totalCashPerShare 0.021
EBITDA
Total Debt 5.01M
quickRatio 0.303
currentRatio 0.313
Total Revenue
debtToEquity
Revenue/Share
ROA -1.4038299
ROE
grossProfits
freeCashflow -1.80M
operatingCashflow -3.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 6.57M
forwardPE
floatShares 51.34M
sharesOutstanding 96.42M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.01%
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.052
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -4.79M
trailingEps -0.03%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated April 16, 2024, 8:13 p.m.